Remich S, Kitchin N, Peterson J, Li P, et al. A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses of a Clostridioides difficile Vaccine in Healthy US Adults 65 to 85 Years of Age. J Infect Dis 2023 Aug 2:jiad307. doi: 10.1093.
PMID: 37531657